Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Cerebrolysin to Recover Aphasia in Patients with Acute Ischemic Stroke
TCTR20251122002Phase 2Recruiting
- Sponsor
- Sakolawat Jaroenpakdee
- Start
- Jun 2025
- Modality
- Peptide-based Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Native Peptides → Peptides, Modified Peptides → Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cerebrolysin in ischemic stroke, aphasia, sponsored by Sakolawat Jaroenpakdee. Started Jun 2025; status: recruiting.
02
Drugs
cerebrolysin
03
Conditions
ischemic strokeaphasia
Beyond the preview
Go deeper on TCTR20251122002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251122002.